🇺🇸 FDA
Patent

US 11407990

Fusion proteins and methods for site-directed genome editing

granted A61KA61K38/00

Quick answer

US patent 11407990 (Fusion proteins and methods for site-directed genome editing) held by The Regents of the University of California expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00